“Cellular Goods are on the forefront of creating premium shopper cannabinoid merchandise within the United Kingdom,” stated Trevor Peters, Willow’s CEO
Cellular Goods PLC (LON:CBX) signed a multi-year supply agreement for cannabigerol (CBG) with Toronto-listed Willow Biosciences.
Willow will supply Cellular Goods with its proprietary, ultra-pure, biosynthetically produced, cannabigerol for use in Cellular Goods’ premium cannabinoid-based skincare merchandise which might be launched within the autumn of 2021.
“Successful merchandise begin with the perfect components and having the ability to supply constant, extremely pure cannabinoids by way of mobile agriculture from a trusted supplier like Willow is crucial to our enterprise. CBG is probably the most promising cannabinoid for skincare functions and we imagine it’s going to turn out to be a must have improve to individuals’s day by day routines,” stated Alexis Abraham, the chief govt officer of Cellular Goods.
“Cellular Goods would be the first to carry a range to market within the UK constructed on our core rules of delivering efficacy-led and research-backed shopper cannabinoid merchandise,” Abraham added.
Shares in Cellular Goods rose 2.8% to 7.25p following the announcement.
